At the time of writing, Oruka Therapeutics Inc [ORKA] stock is trading at $29.87, up 1.98%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The ORKA shares have gain 5.81% over the last week, with a monthly amount glided 9.61%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Oruka Therapeutics Inc [NASDAQ: ORKA] stock has seen the most recent analyst activity on November 13, 2025, when Jefferies initiated its Buy rating and assigned the stock a price target of $45. Previously, Guggenheim started tracking the stock with Buy rating on October 27, 2025, and set its price target to $60. On October 13, 2025, Barclays initiated with an Overweight rating and assigned a price target of $48 on the stock. BTIG Research started tracking the stock assigning a Buy rating and suggested a price target of $44 on May 22, 2025. Wolfe Research initiated its recommendation with an Outperform and recommended $20 as its price target on February 04, 2025. Stifel started tracking with a Buy rating for this stock on October 11, 2024, and assigned it a price target of $49. In a note dated October 07, 2024, H.C. Wainwright initiated a Buy rating and provided a target price of $45 on this stock.
For the past year, the stock price of Oruka Therapeutics Inc fluctuated between $5.49 and $29.98. Currently, Wall Street analysts expect the stock to reach $49.33 within the next 12 months. Oruka Therapeutics Inc [NASDAQ: ORKA] shares were valued at $29.87 at the most recent close of the market. An investor can expect a potential return of 65.15% based on the average ORKA price forecast.
Analyzing the ORKA fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.2, Equity is -0.26 and Total Capital is -0.24. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 29.16 points at the first support level, and at 28.45 for the second support level. However, for the 1st resistance point, the stock is sitting at 30.72, and for the 2nd resistance point, it is at 31.56.
Ratios To Look Out For
It is important to note that Oruka Therapeutics Inc [NASDAQ:ORKA] has a current ratio of 16.94. Also, the Quick Ratio is 16.94, while the Cash Ratio stands at 4.35.
Transactions by insiders
Recent insider trading involved Venrock Healthcare Capital Par, 10% Owner, that happened on Feb 14 ’25 when 88794.0 shares were purchased. 10% Owner, Venrock Healthcare Capital Par completed a deal on Feb 13 ’25 to buy 14950.0 shares. Meanwhile, 10% Owner Venrock Healthcare Capital Par bought 8971.0 shares on Feb 12 ’25.
